vs

Side-by-side financial comparison of Natera, Inc. (NTRA) and Utz Brands, Inc. (UTZ). Click either name above to swap in a different company.

Natera, Inc. is the larger business by last-quarter revenue ($665.5M vs $361.3M, roughly 1.8× Utz Brands, Inc.). On growth, Natera, Inc. posted the faster year-over-year revenue change (39.8% vs 2.6%). Over the past eight quarters, Natera, Inc.'s revenue compounded faster (34.5% CAGR vs -0.2%).

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...

Utz Brands, Inc., more commonly known as Utz, is an American snack food company based in Hanover, Pennsylvania. The company produces a variety of potato chips, pretzels, and other snacks, with most products sold under their family of brands. Utz is also a snack supplier to warehouse clubs and merchandisers.

NTRA vs UTZ — Head-to-Head

Bigger by revenue
NTRA
NTRA
1.8× larger
NTRA
$665.5M
$361.3M
UTZ
Growing faster (revenue YoY)
NTRA
NTRA
+37.2% gap
NTRA
39.8%
2.6%
UTZ
Faster 2-yr revenue CAGR
NTRA
NTRA
Annualised
NTRA
34.5%
-0.2%
UTZ

Income Statement — Q4 FY2025 vs Q1 FY2027

Metric
NTRA
NTRA
UTZ
UTZ
Revenue
$665.5M
$361.3M
Net Profit
$47.3M
Gross Margin
25.4%
Operating Margin
-3.4%
2.2%
Net Margin
7.1%
Revenue YoY
39.8%
2.6%
Net Profit YoY
187.9%
EPS (diluted)
$0.36
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NTRA
NTRA
UTZ
UTZ
Q1 26
$361.3M
Q4 25
$665.5M
Q3 25
$592.2M
Q2 25
$546.6M
Q1 25
$501.8M
Q4 24
$476.1M
$341.0M
Q3 24
$439.8M
$365.5M
Q2 24
$413.4M
$356.2M
Net Profit
NTRA
NTRA
UTZ
UTZ
Q1 26
Q4 25
$47.3M
Q3 25
$-87.5M
Q2 25
$-100.9M
Q1 25
$-66.9M
Q4 24
$-53.8M
$2.3M
Q3 24
$-31.6M
$-2.2M
Q2 24
$-37.5M
$19.8M
Gross Margin
NTRA
NTRA
UTZ
UTZ
Q1 26
25.4%
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
25.5%
Q3 24
26.9%
Q2 24
26.7%
Operating Margin
NTRA
NTRA
UTZ
UTZ
Q1 26
2.2%
Q4 25
-3.4%
Q3 25
-16.5%
Q2 25
-20.2%
Q1 25
-15.8%
Q4 24
-13.6%
2.1%
Q3 24
-8.9%
5.3%
Q2 24
-10.6%
6.3%
Net Margin
NTRA
NTRA
UTZ
UTZ
Q1 26
Q4 25
7.1%
Q3 25
-14.8%
Q2 25
-18.5%
Q1 25
-13.3%
Q4 24
-11.3%
0.7%
Q3 24
-7.2%
-0.6%
Q2 24
-9.1%
5.6%
EPS (diluted)
NTRA
NTRA
UTZ
UTZ
Q1 26
$-0.02
Q4 25
$0.36
Q3 25
$-0.64
Q2 25
$-0.74
Q1 25
$-0.50
Q4 24
$-0.41
$0.04
Q3 24
$-0.26
$-0.03
Q2 24
$-0.30
$0.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NTRA
NTRA
UTZ
UTZ
Cash + ST InvestmentsLiquidity on hand
$73.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.7B
$709.5M
Total Assets
$2.4B
$2.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NTRA
NTRA
UTZ
UTZ
Q1 26
$73.7M
Q4 25
Q3 25
$1.0M
Q2 25
$16.0M
Q1 25
$17.8M
Q4 24
$22.7M
$56.1M
Q3 24
$29.5M
$64.9M
Q2 24
$90.3M
$66.6M
Total Debt
NTRA
NTRA
UTZ
UTZ
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$768.6M
Q3 24
$780.8M
Q2 24
$797.6M
Stockholders' Equity
NTRA
NTRA
UTZ
UTZ
Q1 26
$709.5M
Q4 25
$1.7B
Q3 25
$1.3B
Q2 25
$1.2B
Q1 25
$1.2B
Q4 24
$1.2B
$696.9M
Q3 24
$878.5M
$685.7M
Q2 24
$836.5M
$686.0M
Total Assets
NTRA
NTRA
UTZ
UTZ
Q1 26
$2.8B
Q4 25
$2.4B
Q3 25
$1.8B
Q2 25
$1.8B
Q1 25
$1.7B
Q4 24
$1.7B
$2.7B
Q3 24
$1.6B
$2.6B
Q2 24
$1.5B
$2.7B
Debt / Equity
NTRA
NTRA
UTZ
UTZ
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
1.10×
Q3 24
1.14×
Q2 24
1.16×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NTRA
NTRA
UTZ
UTZ
Operating Cash FlowLast quarter
$73.9M
$-12.2M
Free Cash FlowOCF − Capex
$37.8M
FCF MarginFCF / Revenue
5.7%
Capex IntensityCapex / Revenue
5.4%
3.8%
Cash ConversionOCF / Net Profit
1.56×
TTM Free Cash FlowTrailing 4 quarters
$109.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NTRA
NTRA
UTZ
UTZ
Q1 26
$-12.2M
Q4 25
$73.9M
Q3 25
$59.4M
Q2 25
$37.6M
Q1 25
$44.5M
Q4 24
$52.9M
$54.2M
Q3 24
$51.8M
$52.2M
Q2 24
$4.0M
$8.9M
Free Cash Flow
NTRA
NTRA
UTZ
UTZ
Q1 26
Q4 25
$37.8M
Q3 25
$37.0M
Q2 25
$11.7M
Q1 25
$22.6M
Q4 24
$34.8M
$16.5M
Q3 24
$35.5M
$29.1M
Q2 24
$-7.7M
$-15.3M
FCF Margin
NTRA
NTRA
UTZ
UTZ
Q1 26
Q4 25
5.7%
Q3 25
6.2%
Q2 25
2.1%
Q1 25
4.5%
Q4 24
7.3%
4.8%
Q3 24
8.1%
8.0%
Q2 24
-1.9%
-4.3%
Capex Intensity
NTRA
NTRA
UTZ
UTZ
Q1 26
3.8%
Q4 25
5.4%
Q3 25
3.8%
Q2 25
4.7%
Q1 25
4.3%
Q4 24
3.8%
11.1%
Q3 24
3.7%
6.3%
Q2 24
2.8%
6.8%
Cash Conversion
NTRA
NTRA
UTZ
UTZ
Q1 26
Q4 25
1.56×
Q3 25
Q2 25
Q1 25
Q4 24
23.67×
Q3 24
Q2 24
0.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons